First patient enrolled in LYNX-2 Phase 3 study
The LYNX-2 Phase 3 study is evaluating phentolamine ophthalmic solution 0.75% for the treatment of decreased visual acuity under low light conditions following keratorefractive surgery
The LYNX-2 Phase 3 study is evaluating phentolamine ophthalmic solution 0.75% for the treatment of decreased visual acuity under low light conditions following keratorefractive surgery
The company announced results from a Phase IV study of tropicamide and phenylephrine hydrochloride ophthalmic spray 1%/2.5% (Mydcombi) designed to characterize the efficacy and duration…
Neda Nikpoor, MD, urges audience members to become more empowered in making small but meaningful, evidence-based changes in combating unconscious gender bias.
Emily Schehlein, MD, recaps her article, “Establishing a Glaucoma Practice Fresh Out of Fellowship,” which was featured in the March/April issue of Glaucoma Today. When…
WHERE IT ALL BEGAN Coming from a family of doctors, I was eager to buck the tradition after studying political science and philosophy at Carleton…
El síndrome del ojo seco ocurre cuando sus ojos no producen suficientes lágrimas para permanecer húmedos. Síntomas, causas, diagnóstico y tratamiento.
A study conducted on a nationally representative sample of older adults showed that access to digital technology is hampered by vision impairment, potentially limiting access…
Each year the National Eye Institute (NEI) leads or supports many clinical trials and studies that help researchers learn more about eye problems and how…
Retinal physicians face increasing pressure from government regulators and payors on various issues. To avoid regulatory scrutiny, it’s vital for practice administrators and owners to…
Researchers used an imaging technology called adaptive optics to identify rare cells that could help fill in the gaps in existing theories of color perception.